10 April 2018

ASX Announcement

Penthrox is approved in Canada

Medical Developments International Limited (ASX:MVP), announce today that PENTHROX®, has been granted Market Authorisation in Canada. The Marketing Authorisation issued by Health Canada allows PENTHROX® to be used for the short-term relief of moderate to severe acute pain, associated with trauma or interventional medical procedures, in conscious adult patients1.

For the full release, please refer to the following link: ASX Announcement - Penthrox is approved in Canada

Attachments

  • Original document
  • Permalink

Disclaimer

Medical Developments International Limited published this content on 10 April 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 10 April 2018 02:45:04 UTC